These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 22648863)

  • 21. Protein aggregation kinetics during Protein A chromatography. Case study for an Fc fusion protein.
    Shukla AA; Gupta P; Han X
    J Chromatogr A; 2007 Nov; 1171(1-2):22-8. PubMed ID: 17920607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Understanding the Role of Preferential Exclusion of Sugars and Polyols from Native State IgG1 Monoclonal Antibodies and its Effect on Aggregation and Reversible Self-Association.
    Sudrik CM; Cloutier T; Mody N; Sathish HA; Trout BL
    Pharm Res; 2019 May; 36(8):109. PubMed ID: 31127417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acetate- and Citrate-Specific Ion Effects on Unfolding and Temperature-Dependent Aggregation Rates of Anti-Streptavidin IgG1.
    Barnett GV; Razinkov VI; Kerwin BA; Hillsley A; Roberts CJ
    J Pharm Sci; 2016 Mar; 105(3):1066-73. PubMed ID: 26886346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of polyol sugars on the stabilization of monoclonal antibodies.
    Nicoud L; Cohrs N; Arosio P; Norrant E; Morbidelli M
    Biophys Chem; 2015 Feb; 197():40-6. PubMed ID: 25645712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cation exchange surface-mediated denaturation of an aglycosylated immunoglobulin (IgG1).
    Gillespie R; Nguyen T; Macneil S; Jones L; Crampton S; Vunnum S
    J Chromatogr A; 2012 Aug; 1251():101-110. PubMed ID: 22771262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening of monoclonal antibody formulations based on high-throughput thermostability and viscosity measurements: design of experiment and statistical analysis.
    He F; Woods CE; Trilisky E; Bower KM; Litowski JR; Kerwin BA; Becker GW; Narhi LO; Razinkov VI
    J Pharm Sci; 2011 Apr; 100(4):1330-40. PubMed ID: 24081468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experimental Model System to Study pH Shift-Induced Aggregation of Monoclonal Antibodies Under Controlled Conditions.
    Oyetayo OO; Kiefer H
    Pharm Res; 2016 Jun; 33(6):1359-69. PubMed ID: 26928669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Examination of thermal unfolding and aggregation profiles of a series of developable therapeutic monoclonal antibodies.
    Brader ML; Estey T; Bai S; Alston RW; Lucas KK; Lantz S; Landsman P; Maloney KM
    Mol Pharm; 2015 Apr; 12(4):1005-17. PubMed ID: 25687223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of freezing on pH of buffered solutions and consequences for monoclonal antibody aggregation.
    Kolhe P; Amend E; Singh SK
    Biotechnol Prog; 2010; 26(3):727-33. PubMed ID: 20039442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of Protein Conformation, Apparent Solubility, and Protein-Protein Interactions on the Rates and Mechanisms of Aggregation for an IgG1Monoclonal Antibody.
    Kalonia C; Toprani V; Toth R; Wahome N; Gabel I; Middaugh CR; Volkin DB
    J Phys Chem B; 2016 Jul; 120(29):7062-75. PubMed ID: 27380437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Excipients on Liquid-Liquid Phase Separation and Aggregation in Dual Variable Domain Immunoglobulin Protein Solutions.
    Raut AS; Kalonia DS
    Mol Pharm; 2016 Mar; 13(3):774-83. PubMed ID: 26756795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigation of N-terminal glutamate cyclization of recombinant monoclonal antibody in formulation development.
    Yu L; Vizel A; Huff MB; Young M; Remmele RL; He B
    J Pharm Biomed Anal; 2006 Oct; 42(4):455-63. PubMed ID: 16828250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of ionic strength and pH on the physical and chemical stability of a monoclonal antibody antigen-binding fragment.
    Wang T; Kumru OS; Yi L; Wang YJ; Zhang J; Kim JH; Joshi SB; Middaugh CR; Volkin DB
    J Pharm Sci; 2013 Aug; 102(8):2520-37. PubMed ID: 23824562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quality by design: impact of formulation variables and their interactions on quality attributes of a lyophilized monoclonal antibody.
    Awotwe-Otoo D; Agarabi C; Wu GK; Casey E; Read E; Lute S; Brorson KA; Khan MA; Shah RB
    Int J Pharm; 2012 Nov; 438(1-2):167-75. PubMed ID: 22944306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlating excipient effects on conformational and storage stability of an IgG1 monoclonal antibody with local dynamics as measured by hydrogen/deuterium-exchange mass spectrometry.
    Manikwar P; Majumdar R; Hickey JM; Thakkar SV; Samra HS; Sathish HA; Bishop SM; Middaugh CR; Weis DD; Volkin DB
    J Pharm Sci; 2013 Jul; 102(7):2136-51. PubMed ID: 23620222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization and stability study of polysorbate 20 in therapeutic monoclonal antibody formulation by multidimensional ultrahigh-performance liquid chromatography-charged aerosol detection-mass spectrometry.
    Li Y; Hewitt D; Lentz YK; Ji JA; Zhang TY; Zhang K
    Anal Chem; 2014 May; 86(10):5150-7. PubMed ID: 24749737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of cosolutes in the aggregation kinetics of monoclonal antibodies.
    Nicoud L; Sozo M; Arosio P; Yates A; Norrant E; Morbidelli M
    J Phys Chem B; 2014 Oct; 118(41):11921-30. PubMed ID: 25243487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Weak antibody-cyclodextrin interactions determined by quartz crystal microbalance and dynamic/static light scattering.
    Härtl E; Dixit N; Besheer A; Kalonia D; Winter G
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):781-9. PubMed ID: 23685354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of solvent environment on the conformation and stability of human polyclonal IgG in solution.
    Szenczi A; Kardos J; Medgyesi GA; Závodszky P
    Biologicals; 2006 Mar; 34(1):5-14. PubMed ID: 16168667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural characterization of IgG1 mAb aggregates and particles generated under various stress conditions.
    Telikepalli SN; Kumru OS; Kalonia C; Esfandiary R; Joshi SB; Middaugh CR; Volkin DB
    J Pharm Sci; 2014 Mar; 103(3):796-809. PubMed ID: 24452866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.